Neurophysiological impairments in IDDM patients during euglycemia and hypoglycemia
- PMID: 8299432
- DOI: 10.2337/diacare.16.11.1438
Neurophysiological impairments in IDDM patients during euglycemia and hypoglycemia
Abstract
Objective: To test the hypothesis that latencies of evoked potentials in IDDM patients are delayed compared with healthy control subjects during euglycemia, and that insulin-induced hypoglycemia causes further latency delays of evoked potentials to occur.
Research design and methods: We recruited 23 IDDM patients (27.9 +/- 1.6 yr of age, HbA1c 6.7 +/- 0.3%, without sensory or autonomic neuropathy) and 26 unequivocally healthy subjects who were carefully matched for sex, age, and body mass index to serve as the control group (18 men and 8 women, 28.4 +/- 1.6 yr of age, 22.6 +/- 0.7 kg/m2), for a controlled, prospective study. Sequential euglycemic-hypoglycemic clamps were performed with stable glycemic plateaus of 5.6, 3.3, 2.2, and 1.7 mM, at which the patients' and healthy control subjects' neurophysiological functions were evaluated. The methodological armamentarium included the measurement of brainstem auditory, middle-latency auditory, and somatosensory evoked potentials that assessed conduction velocity in corresponding neural structures and information processing in the midbrain and auditory cortex.
Results: Multiple analysis of variance revealed a significant overall difference of brainstem auditory evoked potential latencies during euglycemia between the study group and healthy control group (F = 3.41, P < 0.03), which was mainly attributable to latency delays of wave III (F = 6.60, P < 0.02), V (F = 9.19, P < 0.01), and interpeak latency I-V (F = 2.82, P < 0.07). Repeated analysis of variance measures detected a significant latency delay of the major wave Pa of the middle-latency auditory evoked potentials during hypoglycemia (F = 4.4, P < 0.02), which rapidly returned to normal after reinstitution of euglycemia.
Conclusions: In IDDM patients, chronic, structural CNS changes already appear at the brainstem level during euglycemia. Functional, reversible CNS changes, however, seem to emerge during acute deviation from glucose homeostasis in more rostral brain regions.
Similar articles
-
Compromised hormonal counterregulation, symptom awareness, and neurophysiological function after recurrent short-term episodes of insulin-induced hypoglycemia in IDDM patients.Diabetes. 1993 Apr;42(4):610-8. doi: 10.2337/diab.42.4.610. Diabetes. 1993. PMID: 8384134
-
Brainstem auditory evoked potentials and visually evoked potentials in young patients with IDDM.Diabetes Care. 1996 Nov;19(11):1220-4. doi: 10.2337/diacare.19.11.1220. Diabetes Care. 1996. PMID: 8908383
-
Mild hypoglycemia and impairment of brain stem and cortical evoked potentials in healthy subjects.Diabetes. 1990 Dec;39(12):1550-5. doi: 10.2337/diab.39.12.1550. Diabetes. 1990. PMID: 2245879
-
Changes in brainstem auditory evoked potentials during insulin-induced hypoglycaemia in type 1 diabetic patients.Diabet Med. 1991 Nov;8(9):805-11. doi: 10.1111/j.1464-5491.1991.tb02117.x. Diabet Med. 1991. PMID: 1837506
-
Average evoked potentials--clinical applications of short latency responses.Indian J Physiol Pharmacol. 1998 Apr;42(2):172-88. Indian J Physiol Pharmacol. 1998. PMID: 10225045 Review.
Cited by
-
Abnormalities in evoked potentials associated with abnormal glycemia and brain injury in neonatal hypoxic-ischemic encephalopathy.Clin Neurophysiol. 2021 Jan;132(1):307-313. doi: 10.1016/j.clinph.2020.09.024. Epub 2020 Oct 22. Clin Neurophysiol. 2021. PMID: 33158762 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical